Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up
Authors:
- 5 December 2017
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 26 (5) , 1607-1615
Abstract
The purpose of this study was to evaluate a new care model to reduce chemotherapy-induced neuropathic symptoms. Neuropathic symptom usual care was prospectively compared to an automated symptom-monitoring and coaching system, SymptomCare@Home (SCH), which included nurse practitioner follow-up triggered by moderate to severe symptoms.Keywords
Funding Information
- National Institutes of Health (R01 CA120558, KL2TR001065)
This publication has 25 references indexed in Scilit:
- Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES RegistryJournal of Clinical Oncology, 2013
- Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP studySupportive Care in Cancer, 2013
- Chemotherapy-induced peripheral neurotoxicity (CIPN): An updateCritical Reviews in Oncology/Hematology, 2012
- Falls in persons with chemotherapy-induced peripheral neuropathySupportive Care in Cancer, 2011
- How to Identify Patients with Cancer at Risk of Falling: A Review of the EvidenceJournal of Palliative Medicine, 2011
- Surviving Chemotherapy for Colon Cancer and Living with the ConsequencesJournal of Palliative Medicine, 2010
- Outpatient Chemotherapy: Patients' and Family Members' Concerns and Coping StrategiesPublic Health Nursing, 1992
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Efficacy of proactive information on self-care in chemotherapy patientsPatient Education and Counseling, 1988
- ChemotherapyCancer Nursing, 1981